Researcher discovers mechanism to slow tumor growth and metastasis in breast cancer

by Cindy Young

(Medical Xpress)—Wright State University Boonshoft School of Medicine professor Julian Gomez-Cambronero, Ph.D., and his research team have discovered a key protein that plays a critical role in the development of breast cancer tumors and the spread of the disease to the nearby lungs.

Cambronero's findings, published this month in the leading cancer journal Oncogene (click here for the report), attribute the cancer's growth to a protein called Phospholipase D (PLD). Cambronero and his team found that by introducing two new of PLD they could shrink tumor growth and reduce subsequent metastasis by around 70 percent.

"Although it's still early to tell, the application of these inhibitors to research in human tissue is the next step that could lead to better, less toxic treatments in the battle against ," said Cambronero, a professor of biochemistry and molecular biology.

Breast cancer kills more women in the United States each year—about 40,000—than any other type of cancer, according to the National Cancer Institute. The disease strikes an estimated 232,340 females each year and 2,240 males.

add to favorites email to friend print save as pdf

Related Stories

Study finds new drug target for metastatic breast cancer

Apr 11, 2013

Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the ...

Developmental protein plays role in spread of cancer

Jun 14, 2013

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers ...

Recommended for you

Blood biomarker may detect lung cancer

15 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

Oct 20, 2014

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments